New antiviral pill for COVID cut hospital and death risk by 89%, Pfizer says

뉴스
Author
PhillyKo
Date
2021-11-05 16:33
Views
69
Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% as the drugmaker joins the race to bring the first easy-to-use medication against the coronavirus to the U.S. market.

Currently all COVID-19 treatments used in the U.S. require an IV or injection. Competitor Merck's COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and on Thursday the United Kingdom became the first country to approve it.

Pfizer said it will ask the FDA and international regulators to authorize its pill as soon as possible, after independent experts recommended halting the company's study based on the strength of its results. Once Pfizer applies, the FDA could make a decision within weeks or months.

Researchers worldwide have been racing to find a pill against COVID-19 that can be taken at home to ease symptoms, speed recovery and reduce the crushing burden on hospitals and doctors.

Pfizer released preliminary results Friday of its study of 775 adults. Patients taking the company's drug along with another antiviral had an 89% reduction in their combined rate of hospitalization or death after a month, compared to patients taking a dummy pill. Fewer than 1% of patients taking the drug needed to be hospitalized and no one died. In the comparison group, 7% were hospitalized and there were seven deaths.

"We were hoping that we had something extraordinary, but it's rare that you see great drugs come through with almost 90% efficacy and 100% protection for death," said Dr. Mikael Dolsten, Pfizer's chief scientific officer, in an interview.

Study participants were unvaccinated, with mild-to-moderate COVID-19, and were considered high risk for hospitalization due to health problems like obesity, diabetes or heart disease. Treatment began within three to five days of initial symptoms, and lasted for five days.

Pfizer reported few details on side effects but said rates of problems were similar between the groups at about 20%.

An independent group of medical experts monitoring the trial recommended stopping it early, standard procedure when interim results show such a clear benefit. The data have not yet been published for outside review, the normal process for vetting new medical research.

Top U.S. health officials continue to stress that vaccination will remain the best way to protect against infection. But with tens of millions of adults still unvaccinated - and many more globally - effective, easy-to-use treatments will be critical to curbing future waves of infections.

The FDA has set a public meeting later this month to review Merck's pill, known as molnupiravir. The company reported in September that its drug cut rates of hospitalization and death by 50%. Experts warn against comparing preliminary results because of differences in studies.

Although Merck's pill is further along in the U.S. regulatory process, Pfizer's drug could benefit from a safety profile that is more familiar to regulators with fewer red flags. While pregnant women were excluded from the Merck trial due to a potential risk of birth defects, Pfizer's drug did not have any similar restrictions. The Merck drug works by interfering with the coronavirus' genetic code, a novel approach to disrupting the virus.

Pfizer's drug is part of a decades-old family of antiviral drugs known as protease inhibitors, which revolutionized the treatment of HIV and hepatitis C. The drugs block a key enzyme which viruses need to multiply in the human body.

The drug, which has not yet been named, was first identified during the SARS outbreak originating in Asia during 2003. Last year, company researchers decided to revive the medication and study it for COVID-19, given the similarities between the two coronaviruses.

The U.S. has approved one other antiviral drug for COVID-19, remdesivir, and authorized three antibody therapies that help the immune system fight the virus. But they have to be given by IV or injection at hospitals or clinics, and limited supplies were strained by the last surge of the delta variant.

Source: https://www.cbsnews.com/news/covid-antiviral-pill-pfizer-cut-hospital-death-risk-by-89-percent/
Total 709
Number Title Author Date Votes Views
Notice
뉴저지 한인회
지은 | 2017.06.25 | Votes 0 | Views 5744
지은 2017.06.25 0 5744
Notice
필라델피아 한인회
Jin | 2017.06.24 | Votes 0 | Views 11511
Jin 2017.06.24 0 11511
700
Waukesha parade suspect charged with 5 counts of homicide, 6th death announced by prosecutors
TAN | 2021.11.23 | Votes 0 | Views 10
TAN 2021.11.23 0 10
699
FDA authorizes Pfizer and Moderna boosters for all adults
TAN | 2021.11.19 | Votes 0 | Views 23
TAN 2021.11.19 0 23
698
항공 및 관광 / 건강검진 안내(213-388-4141)
고현정 | 2021.11.12 | Votes 0 | Views 69
고현정 2021.11.12 0 69
697
New antiviral pill for COVID cut hospital and death risk by 89%, Pfizer says
PhillyKo | 2021.11.05 | Votes 0 | Views 69
PhillyKo 2021.11.05 0 69
696
Pfizer says Covid vaccine more than 90 percent effective in children ages 5 to 11
TAN | 2021.10.22 | Votes 0 | Views 161
TAN 2021.10.22 0 161
695
LinkedIn is shutting down its China platform because of a 'challenging operating environment'
TAN | 2021.10.15 | Votes 0 | Views 166
TAN 2021.10.15 0 166
694
Scarlett Johansson and Disney settle 'Black Widow' lawsuit
TAN | 2021.10.01 | Votes 0 | Views 195
TAN 2021.10.01 0 195
693
Parents sue Disney Cruise Line for $20M over alleged sexual assault of 3-year-old daughter
TAN | 2021.09.24 | Votes 0 | Views 186
TAN 2021.09.24 0 186
692
진실
미국 수사관 | 2021.09.08 | Votes 0 | Views 259
미국 수사관 2021.09.08 0 259
691
CMC Scholarship
PhillyKo | 2021.09.03 | Votes 0 | Views 189
PhillyKo 2021.09.03 0 189
690
Videos show historic flooding in New York after Ida blasts the Northeast
TAN | 2021.09.02 | Votes 0 | Views 191
TAN 2021.09.02 0 191
689
Cyberattacks on PH group traced
TAN | 2021.08.27 | Votes 0 | Views 151
TAN 2021.08.27 0 151
688
이미 올린 위키피디아 잘 보세요.
미국 수사관 | 2021.08.15 | Votes 0 | Views 192
미국 수사관 2021.08.15 0 192
687
류현진이가 금방 타팀으로 갔나?
미국 수사관 | 2021.08.15 | Votes 0 | Views 146
미국 수사관 2021.08.15 0 146
686
세상 이렇게 됬다니까?!!
미국 수사관 | 2021.07.29 | Votes 0 | Views 172
미국 수사관 2021.07.29 0 172
685
류현진 뉴욕 메츠에 있는가? 없는가?
미국 수사관 | 2021.07.25 | Votes 0 | Views 186
미국 수사관 2021.07.25 0 186
684
도쿄 2020/2021 올림픽 개막전이 있나?
미국 수사관 | 2021.07.24 | Votes 0 | Views 172
미국 수사관 2021.07.24 0 172
683
작년에 일본 올림픽 하다가 만 필름들을 쏟아 넣으려나?
미국 수사관 | 2021.07.20 | Votes 0 | Views 156
미국 수사관 2021.07.20 0 156
682
일본 올림픽 취소’라고 Google에 타이핑..
미국 수사관 | 2021.07.18 | Votes 0 | Views 157
미국 수사관 2021.07.18 0 157
681
잘 보아야 할 걸...!!
미국 수사관 | 2021.07.11 | Votes 0 | Views 154
미국 수사관 2021.07.11 0 154
New
Advertisement banner 1600 X 175.
Translate »

Log in with your credentials

Forgot your details?